These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25118603)

  • 1. Hepatocellular carcinoma: gender differences.
    Seton-Rogers S
    Nat Rev Cancer; 2014 Sep; 14(9):578. PubMed ID: 25118603
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.
    Hartwell HJ; Petrosky KY; Fox JG; Horseman ND; Rogers AB
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11455-60. PubMed ID: 25049387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-based immunotherapy for hepatocellular carcinoma.
    Onji M; Akbar F; Horiike N
    J Gastroenterol; 2001 Nov; 36(11):794-7. PubMed ID: 11757756
    [No Abstract]   [Full Text] [Related]  

  • 4. [Retinoid].
    Moriwaki H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():764-8. PubMed ID: 11762053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intensification of antineoplastic immunity with the use of chemical heterogenization of tumor tissue antigens].
    Korosteleva TA; Movsesian KS; Aleksanian IuT
    Zh Eksp Klin Med; 1974; 14(3):7-10. PubMed ID: 4370925
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice.
    Kitajima M; Takaku H
    Clin Vaccine Immunol; 2008 Feb; 15(2):376-8. PubMed ID: 18057182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of liver cancer.
    World Health Organ Tech Rep Ser; 1983; 691():1-30. PubMed ID: 6314682
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
    Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ
    Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.
    Dolezal JM; Wang H; Kulkarni S; Jackson L; Lu J; Ranganathan S; Goetzman ES; Bharathi SS; Beezhold K; Byersdorfer CA; Prochownik EV
    J Biol Chem; 2017 Jun; 292(24):10068-10086. PubMed ID: 28432125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice.
    Merle P; Chevallier M; Levy R; Maisonnas M; Terradillos O; Ahmed SNS ; Trépo C; Buendia MA; Vitvitski-Trépo L
    J Hepatol; 2001 Apr; 34(4):562-9. PubMed ID: 11394656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective tumor immunity induced by potassium chloride extracts of guinea pig hepatomas.
    Meltzer MS; Leonard EJ; Hardy AS; Rapp HJ
    J Natl Cancer Inst; 1975 Jun; 54(6):1349-54. PubMed ID: 166188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E3 proteins help tumors to evade innate and adaptive immune responses.
    Sharma S; Andersson A
    Cancer Biol Ther; 2009 Jun; 8(12):1133-5. PubMed ID: 19458480
    [No Abstract]   [Full Text] [Related]  

  • 13. c-myc overexpression in hepatocarcinogenesis.
    Feitelson MA
    Hum Pathol; 2004 Nov; 35(11):1299-302. PubMed ID: 15668885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).
    Lan FF; Wang H; Chen YC; Chan CY; Ng SS; Li K; Xie D; He ML; Lin MC; Kung HF
    Int J Cancer; 2011 Jan; 128(2):319-31. PubMed ID: 20309945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging-based mathematical modeling techniques that enhance the understanding of oncogene addiction in relation to tumor growth.
    Nwabugwu C; Rakhra K; Felsher D; Paik D
    Comput Math Methods Med; 2013; 2013():802512. PubMed ID: 23573174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.
    Buettner N; Thimme R
    Semin Immunopathol; 2019 Mar; 41(2):203-211. PubMed ID: 30498927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IMMUNOLOGICAL FACTORS OF THE INNATE IMMUNITY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA OF A LARGE SIZE].
    Stasenko AA; Kotenko OG; Grinenko AV; Korshak AA; Ostapishen AN
    Klin Khir; 2015 Apr; (4):19-22. PubMed ID: 26263636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc target miRs and liver cancer: small molecules to get Myc sick.
    Buendia MA; Bourre L; Cairo S
    Gastroenterology; 2012 Feb; 142(2):214-8. PubMed ID: 22178210
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B virus infection, its sequelae, and prevention by vaccination.
    Huang LM; Lu CY; Chen DS
    Curr Opin Immunol; 2011 Apr; 23(2):237-43. PubMed ID: 21257300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.